Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Nicholson

Showing results (221-230 of 357) with videos related to

Pageof 36
Sort By:
Endocrine-Related Cancer|August 23, 2005
Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancerJ M Gee, J F Robertson, E Gutteridge, et al.
Breast Cancer Research and Treatment|March 17, 2009
Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistanceNicholas B P Thomas, Iain R Hutcheson, Lee Campbell, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1989
Endocrine effects of combination antioestrogen and LH-RH agonist therapy in premenopausal patients with advanced breast cancerK J Walker, R F Walker, A Turkes, et al.
British Journal of Cancer|October 1, 1989
Invasive lobular carcinomas of the breast--the prognosis of histopathological subtypesR S du Toit, A P Locker, I O Ellis, et al.
The British Journal of Surgery|May 1, 1984
The relationship of background mammographic pattern to hormone dependency in breast cancerC P Hinton, M R Williams, E J Roebuck, et al.
AJR. American Journal of Roentgenology|June 1, 1985
Mammographic parenchymal patterns: value as a predictor of hormone dependency and survival in breast cancerC P Hinton, E J Roebuck, M R Williams, et al.
Endocrine-Related Cancer|January 30, 2007
Deciphering antihormone-induced compensatory mechanisms in breast cancer and their therapeutic implicationsJ M W Gee, V E Shaw, S E Hiscox, et al.
Journal of Clinical Pathology|October 30, 2007
Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancerJ W Assender, J M W Gee, I Lewis, et al.
Clinical Breast Cancer|December 3, 2014
A good drug made better: the fulvestrant dose-response storyJohn F R Robertson, Justin Lindemann, Sally Garnett, et al.
Annals of the Royal College of Surgeons of England|March 1, 1990
A randomised controlled trial of medroxyprogesterone acetate in mastalgiaP R Maddox, B J Harrison, J M Horobin, et al.
Pageof 36

Showing results (221-230 of 357) with videos related to

Sort By:
Pageof 36
Endocrine-Related Cancer|August 23, 2005
Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancerJ M Gee, J F Robertson, E Gutteridge, et al.
Breast Cancer Research and Treatment|March 17, 2009
Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistanceNicholas B P Thomas, Iain R Hutcheson, Lee Campbell, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1989
Endocrine effects of combination antioestrogen and LH-RH agonist therapy in premenopausal patients with advanced breast cancerK J Walker, R F Walker, A Turkes, et al.
British Journal of Cancer|October 1, 1989
Invasive lobular carcinomas of the breast--the prognosis of histopathological subtypesR S du Toit, A P Locker, I O Ellis, et al.
The British Journal of Surgery|May 1, 1984
The relationship of background mammographic pattern to hormone dependency in breast cancerC P Hinton, M R Williams, E J Roebuck, et al.
AJR. American Journal of Roentgenology|June 1, 1985
Mammographic parenchymal patterns: value as a predictor of hormone dependency and survival in breast cancerC P Hinton, E J Roebuck, M R Williams, et al.
Endocrine-Related Cancer|January 30, 2007
Deciphering antihormone-induced compensatory mechanisms in breast cancer and their therapeutic implicationsJ M W Gee, V E Shaw, S E Hiscox, et al.
Journal of Clinical Pathology|October 30, 2007
Protein kinase C isoform expression as a predictor of disease outcome on endocrine therapy in breast cancerJ W Assender, J M W Gee, I Lewis, et al.
Clinical Breast Cancer|December 3, 2014
A good drug made better: the fulvestrant dose-response storyJohn F R Robertson, Justin Lindemann, Sally Garnett, et al.
Annals of the Royal College of Surgeons of England|March 1, 1990
A randomised controlled trial of medroxyprogesterone acetate in mastalgiaP R Maddox, B J Harrison, J M Horobin, et al.
Pageof 36